ReShape Lifesciences Inc (RSLS) — Cash Flow-to-Debt Ratio
ReShape Lifesciences Inc (RSLS) has a Cash Flow-to-Debt Ratio of -1.40x as of June 2025, meaning its operating cash flow of $-4.49 Million could theoretically repay -1% of its total liabilities ($3.20 Million) in one year. Check ReShape Lifesciences Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ReShape Lifesciences Inc Cash Flow-to-Debt Ratio (2005–2024)
Historical debt coverage capacity for ReShape Lifesciences Inc across 20 annual periods. Also explore RSLS total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ReShape Lifesciences Inc (2005–2024)
Year-by-year debt coverage analysis for ReShape Lifesciences Inc. For market capitalisation and broader financial context, see ReShape Lifesciences Inc (RSLS) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.88x | $-4.43 Million | $5.05 Million | ▲ +79.3% |
| 2023 | -4.24x | $-16.96 Million | $4.00 Million | ▼ -44.8% |
| 2022 | -2.93x | $-21.90 Million | $7.48 Million | ▼ -55.9% |
| 2021 | -1.88x | $-15.38 Million | $8.19 Million | ▼ -395.9% |
| 2020 | -0.38x | $-8.55 Million | $22.57 Million | ▲ +58.5% |
| 2019 | -0.91x | $-14.20 Million | $15.55 Million | ▲ +51.5% |
| 2018 | -1.88x | $-27.49 Million | $14.61 Million | ▲ +5.6% |
| 2017 | -1.99x | $-24.59 Million | $12.34 Million | ▲ +60.4% |
| 2016 | -5.04x | $-20.66 Million | $4.10 Million | ▼ -76.3% |
| 2015 | -2.86x | $-22.61 Million | $7.91 Million | ▼ -13.8% |
| 2014 | -2.51x | $-19.38 Million | $7.72 Million | ▼ -59.5% |
| 2013 | -1.57x | $-18.43 Million | $11.71 Million | ▲ +0.4% |
| 2012 | -1.58x | $-22.48 Million | $14.22 Million | ▲ +1.3% |
| 2011 | -1.60x | $-19.94 Million | $12.44 Million | ▼ -5.3% |
| 2010 | -1.52x | $-13.66 Million | $8.98 Million | ▲ +34.4% |
| 2009 | -2.32x | $-24.66 Million | $10.63 Million | ▼ -16.2% |
| 2008 | -2.00x | $-33.67 Million | $16.87 Million | ▼ -17.6% |
| 2007 | -1.70x | $-23.37 Million | $13.77 Million | ▲ +21.7% |
| 2006 | -2.17x | $-16.23 Million | $7.49 Million | ▼ -102.1% |
| 2005 | -1.07x | $-10.28 Million | $9.59 Million | — |